Abstract:ETHNOPHARMACOLOGICAL RELEVANCE: Hepatocellular carcinoma (HCC) as the major histological subtype of primary liver cancer remains one of the most common malignancies worldwide. Due to the complicated molecular pathogenesis of HCC, the option for effective systemic treatment is quite limited. There exists a critical need to explore and evaluate possible alternative strategies for effective control of HCC. With a long history of clinical use, Chinese herbal medicine (CHM) is emerging as a noticeable choice for its multi-level, multi-target and coordinated intervention effects against HCC. With the aids of phytochemistry and molecular biological approaches, in the past decades many CHM-derived compounds have been carefully studied through both preclinical and clinical researches and have shown great potential in novel anti-HCC natural product development. The present review aimed at providing the most recent developments on anti-HCC compounds derived from CHM, especially their underlying pharmacological mechanisms.MATERIALS AND METHODS: A systematic search of anti-HCC compounds from CHM was carried out focusing on literatures published both in English (PubMed, Scopus, Web of Science and Medline) and in Chinese academic databases (Wanfang and CNKI database).RESULTS: In this review, we tried to give a timely and comprehensive update about the anti-HCC effects and targets of several representative CHM-derived compounds, namely curcumin, resveratrol, silibinin, berberine, quercetin, tanshinone II-A and celastrol. Their mechanisms of anti-HCC behaviors, potential side effects or toxicity and future research directions were discussed.CONCLUSION: Herbal compounds derived from CHM are of much significance in devising new drugs and providing unique ideas for the war against HCC. We propose that these breakthrough findings may have important implications for targeted-HCC therapy and modernization of CHM.

From traditional Chinese medicine to rational cancer therapy

Traditional Chinese medicine: a treasured natural resource of anticancer drug research and development.

Chinese Medicinal Herbs as Source of Rational Anticancer Therapy

Molecular target-guided tumor therapy with natural products derived from traditional Chinese medicine

Anticancer Drugs from Traditional Toxic Chinese Medicines

Traditional Chinese medicines (TCMs) for molecular targeted therapies of tumours

Traditional Chinese medicine (TCM) as a source of new anticancer drugs.

Plant natural products: from traditional compounds to new emerging drugs in cancer therapy.

Natural Products As Anticancer Agents: Current Status and Future Perspectives

Fighting Fire with Fire: Poisonous Chinese Herbal Medicine for Cancer Therapy

Natural Products in Cancer Therapy: Past, Present and Future

A Map Describing the Association Between Effective Components of Traditional Chinese Medicine and Signaling Pathways in Cancer Cells in Vitro and in Vivo

Chinese herbal medicine-derived compounds for cancer therapy: A focus on hepatocellular carcinoma

The Role and Mechanisms of Action of Natural Compounds in the Prevention and Treatment of Cancer and Cancer Metastasis

Research Progress on the Synergistic Anti-Tumor Effect of Natural Anti-Tumor Components of Chinese Herbal Medicine Combined with Chemotherapy Drugs

Traditional Chinese medicine for the treatment of cancers of hepatobiliary system: from clinical evidence to drug discovery

Phytotherapeutics in Cancer: From Potential Drug Candidates to Clinical Translation

Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science

Anti-cancer natural products isolated from chinese medicinal herbs

Chemoinformatics approaches for traditional Chinese medicine research and case application in anticancer drug discovery.

Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine